Osteopontin is involved in the development of acquired chemo-resistance of cisplatin in small cell lung cancer. [electronic resource]
Producer: 20100112Description: 176-83 p. digitalISSN:- 1872-8332
- Antineoplastic Agents -- therapeutic use
- Caspase 3 -- metabolism
- Caspase 9 -- metabolism
- Cell Line, Tumor
- Cisplatin -- therapeutic use
- Down-Regulation
- Drug Resistance, Neoplasm -- genetics
- Humans
- Lung Neoplasms -- drug therapy
- Osteopontin -- metabolism
- Proto-Oncogene Proteins c-bcl-2 -- metabolism
- RNA, Messenger -- metabolism
- Small Cell Lung Carcinoma -- drug therapy
- Transfection
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.